Verb Surgical, which started as a collaboration between Johnson & Johnson and Alphabet’s Verily unit for cheaper, smaller, and smarter surgical robots, will be wholly owned by J&J.
Verb Surgical debuts robot-assisted surgery prototype
Verb Surgical, Johnson & Johnson‘s (NYSE:JNJ) joint venture with Google parent Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences, said today that it debuted its 1st digital surgery prototype to its collaboration partners at Ethicon Endo-Surgery and J&J. Robotic surgery, a fast growing field dominated by Intuitive Surgical (NSDQ:ISRG) and its da Vinci system, isn’t using robots yet, according to Verily CEO Andrew Conrad. In…